📍 LONDRA, BİRLEŞİK KRALLIK
16.11.2026 01:08 UTC
UK Focus: Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn
Verified reporting indicates that johnson & Johnson looking to buy eye disease biotech for up to $3.4bn. Additional details from primary dispatches note: Drugmaker’s potential acquisition of Ollin Biosciences is latest i...